Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy

• Main Authors: Huanzhu Qian (Author), Zhen Ye (Author), Yu Hu (Author), Mingquan Wu (Author), Liulin Chen (Author), Linzhen Li (Author), Zhipeng Hu (Author), Qian Zhao (Author), Chen Zhang (Author), Maoyi Yang (Author), Wen Xudong (Author), Qiaobo Ye (Author), Kaihua Qin (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ulcerative colitis (UC) is a chronic inflammatory disease of the intestines that can significantly impact quality of life and lead to various complications. Currently, 5-aminosalicylic acid derivatives, corticosteroids, immunosuppressants, and biologics are the major treatment strategies for UC, but...